#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in skin Metachromatic leukodystrophy Cutaneous T-cell lymphoma stage II Retinal artery occlusion Neuroendocrine cell hyperplasia of infancy Colon cancer Peritoneal neoplasm Progressive supranuclear palsy Anal cancer Non-small cell lung cancer recurrent Cholestatic pruritus Endometrial cancer Chorioretinitis Cholangiocarcinoma Polycystic liver disease More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Life with Disease Mast cell activation syndrome – Trials in Disease Acquired haemophilia – Diagnostics Lymphangioma – Life with Disease Marfan’s syndrome – Trials in Disease Hereditary neuropathic amyloidosis – Basic Information Usher’s syndrome – Treatment Primary immunodeficiency syndrome – Basic Information Medulloblastoma recurrent – Diagnostics Pleomorphic leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pritelivir Sevoflurane Betaine Citrate MALIC ACID Msv/As Milvexian Cloxacillin Sodium Ecoo75 Iti-1284 Alfacalcidol Brimonidine TEDUGLUTIDE Alogliptin Iptacopan Betahistine Dihydrochloride IDP-121 Botaretigene Sparoparvovec Carfilzomib Lomustine Epcoritamab More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma recurrent Lichen planopilaris Squamous cell carcinoma Infant sedation Acarodermatitis Milk allergy Osteonecrosis of jaw Multifocal motor neuropathy Colorectal cancer Alexander disease Immunodeficiency congenital Usher's syndrome Anal fissure Rectosigmoid cancer B-cell lymphoma refractory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Sofiamed OOD

Ulitsa Dimitir Mollov 10, Sofia, 1750, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Durvalumab, Tremelimumab, and Chemotherapy in Patients with Advanced Bladder or Urinary System Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Tremelimumab
    • Carboplatin
    • Cisplatin
    Bulgaria Czechia Hungary Italy Poland Spain

  • Study on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection

    Not recruiting

    2 1
    Investigated Drugs:
    • Zelicapavir
    Bulgaria Czechia The Netherlands Poland Slovakia Spain

  • Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Alpelisib
    • Fulvestrant
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia Czechia Estonia France +11

  • Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia Denmark Finland France +13
Previous Page
1 … 3 4 5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!